| Followers | 183 |
| Posts | 7868 |
| Boards Moderated | 0 |
| Alias Born | 02/06/2010 |
Monday, June 16, 2014 10:10:03 AM
ACHN insiders have recently been dumping their shares for a reason.
They obviously know that ACHN is currently grossly overvalued.
Achillion Pharmaceuticals Director Kishbauch Sells 371,937 Shares @$7.75/Share -Form 4 (Benzinga)
They obviously know that ACHN is currently grossly overvalued.
Achillion Pharmaceuticals Director Kishbauch Sells 371,937 Shares @$7.75/Share -Form 4 (Benzinga)
Recent AAQL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2026 09:16:01 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:20:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 12/12/2025 09:11:45 PM
- Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 12/12/2025 09:05:17 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/05/2025 09:55:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:07:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/02/2025 09:18:31 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/30/2025 08:45:06 PM
